**Core Concept**
The underlying pharmacological principle being tested is the mechanism of action of certain antihypertensive drugs, specifically those that cause tachycardia and fluid retention. These effects are often associated with drugs that stimulate the sympathetic nervous system or block the effects of vasodilators.

**Why the Correct Answer is Right**
The correct answer is likely a mineralocorticoid receptor antagonist (MRA), such as spironolactone, or a thiazide diuretic, which can cause fluid retention and tachycardia. Thiazides work by inhibiting the sodium-chloride cotransporter in the distal convoluted tubule, leading to increased sodium and water excretion, but also causing a mild increase in potassium excretion. This can lead to increased sympathetic tone, causing tachycardia. MRAs, such as spironolactone, block the effects of aldosterone, leading to increased potassium levels and decreased sodium reabsorption, which can also cause fluid retention and tachycardia.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is likely a beta-blocker, which would actually decrease heart rate and fluid retention, making it an incorrect answer.
* **Option B:** This option is likely a calcium channel blocker, which would actually decrease blood pressure and fluid retention, making it an incorrect answer.
* **Option C:** This option is likely an ACE inhibitor, which would actually decrease fluid retention and tachycardia, making it an incorrect answer.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that thiazide diuretics can cause an increase in sympathetic tone, leading to tachycardia, and MRAs can cause hyperkalemia, which can be life-threatening.

**Correct Answer:** C.